Summary
The overall proposal objective is to overcome the barriers to the recruitment of highly qualified PHD or equivalent specialists in gene editing techniques for agriculture applications, in particular CRISPR-Cas 9
Iden Biotechnology S.L. is a private agribiotech company founded in 2005 with the mission to serve the needs of the agri-food industry.
We aim at exploiting CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats), a newly developed technology for targeted genome modification, to produce new cereal varieties with resistance to abiotic stress (resistance to low temperatures, draught and/or salinity).
CRISPR/Cas9, gives scientists the ability to more precisely modify DNA by turning genes on or off or editing DNA. They can pinpoint and remove weakness or insert desired traits already found elsewhere in the species.
There are three main advantages of managing to use this technique for crop improvement: Technical, legislative and competitive:
• The results obtained are similar to what could be obtained through natural mutations and conventional breeding, though it is directed, more precise and quick.
• Besides the technical advantages mentioned above, crops modified with this technique may not fall under the GMOs legislation, opening up new market opportunities, including the European market
• Competitive advantage. The crop biotech sector in Europe could have a new innovation tool to overcome the situation defined by the European Academies Science Advisory Council as: “The E.U. falling behind international competitors in agricultural innovation and this has implications for E.U. goals for science and innovation.”
With the help of the associate recruitment we aim at applying this technology to carry out targeted genome modification in cereals, in particular maize or wheat which will help us the development of new improved crop varieties, opening up new market opportunities.
Iden Biotechnology S.L. is a private agribiotech company founded in 2005 with the mission to serve the needs of the agri-food industry.
We aim at exploiting CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats), a newly developed technology for targeted genome modification, to produce new cereal varieties with resistance to abiotic stress (resistance to low temperatures, draught and/or salinity).
CRISPR/Cas9, gives scientists the ability to more precisely modify DNA by turning genes on or off or editing DNA. They can pinpoint and remove weakness or insert desired traits already found elsewhere in the species.
There are three main advantages of managing to use this technique for crop improvement: Technical, legislative and competitive:
• The results obtained are similar to what could be obtained through natural mutations and conventional breeding, though it is directed, more precise and quick.
• Besides the technical advantages mentioned above, crops modified with this technique may not fall under the GMOs legislation, opening up new market opportunities, including the European market
• Competitive advantage. The crop biotech sector in Europe could have a new innovation tool to overcome the situation defined by the European Academies Science Advisory Council as: “The E.U. falling behind international competitors in agricultural innovation and this has implications for E.U. goals for science and innovation.”
With the help of the associate recruitment we aim at applying this technology to carry out targeted genome modification in cereals, in particular maize or wheat which will help us the development of new improved crop varieties, opening up new market opportunities.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/739778 |
| Start date: | 15-09-2017 |
| End date: | 14-09-2018 |
| Total budget - Public funding: | 72 500,00 Euro - 72 500,00 Euro |
Cordis data
Original description
The overall proposal objective is to overcome the barriers to the recruitment of highly qualified PHD or equivalent specialists in gene editing techniques for agriculture applications, in particular CRISPR-Cas 9Iden Biotechnology S.L. is a private agribiotech company founded in 2005 with the mission to serve the needs of the agri-food industry.
We aim at exploiting CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats), a newly developed technology for targeted genome modification, to produce new cereal varieties with resistance to abiotic stress (resistance to low temperatures, draught and/or salinity).
CRISPR/Cas9, gives scientists the ability to more precisely modify DNA by turning genes on or off or editing DNA. They can pinpoint and remove weakness or insert desired traits already found elsewhere in the species.
There are three main advantages of managing to use this technique for crop improvement: Technical, legislative and competitive:
• The results obtained are similar to what could be obtained through natural mutations and conventional breeding, though it is directed, more precise and quick.
• Besides the technical advantages mentioned above, crops modified with this technique may not fall under the GMOs legislation, opening up new market opportunities, including the European market
• Competitive advantage. The crop biotech sector in Europe could have a new innovation tool to overcome the situation defined by the European Academies Science Advisory Council as: “The E.U. falling behind international competitors in agricultural innovation and this has implications for E.U. goals for science and innovation.”
With the help of the associate recruitment we aim at applying this technology to carry out targeted genome modification in cereals, in particular maize or wheat which will help us the development of new improved crop varieties, opening up new market opportunities.
Status
CLOSEDCall topic
INNOSUP-02-2016Update Date
27-10-2022
Images
No images available.
Geographical location(s)
